Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Summary

The purpose of this study is to identify an optimal dose combination(s) of tipranavir (TPV) and ritonavir (RTV) for antiretroviral treatment naïve HIV-1 infected patients that can be used in pivotal trial by assessing the steady-state pharmacokinetics and short-term efficacy and safety

Timeline

Start

2007-10

Primary completion

2008-05

Completion

—

Drugs

Indications